P1198: ASSOCIATION OF PRETREATMENT TUMOR CHARACTERISTICS AND CLINICAL OUTCOMES FOLLOWING SECOND-LINE AXICABTAGENE CILOLEUCEL VS STANDARD OF CARE IN PATIENTS WITH RELAPSED/REFRACTORY LARGE B-CELL LYMPHOMA. (23rd June 2022) - Locke, F. L.; Chou, J.; Vardhanabhuti, S.; Perbost, R.; Dreger, P.; Hill, B. T.; Lee, C.; Zinzani, P. L.; Kröger, N.; López-Guillermo, A.; Greinix, H.; Zhang, W.; et al.